Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 3Other 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Mucositis 6Head and Neck Neoplasms 3Neoplasms 2Xerostomia 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Oral Ulcer 1Multiple Myeloma 1Leukemia 1Laryngeal Diseases 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Squamous Cell 1

Interventions

Resistance Training 4Nutrition Assessment 4naloxegol 3Surveys and Questionnaires 3Exercise 3alvimopan 2Therapeutics 2Psychiatric Rehabilitation 2Oxygen 2Nutritional Status 2Mouthwashes 2Morphine 2Ketamine 2Interviews as Topic 2Fibroblast Growth Factor 7 2Counseling 2semaglutide 1naldemedine 1methylnaltrexone 1ma zi ren wan 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1dexamethasone acetate 1dexamethasone 21-phosphate 1calcium phosphate 1auricularum 1aluminum hydroxide, magnesium hydroxide, drug combination 1Weights and Measures 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Fibroblast Growth Factor 7 × Other × Clear all
NCT00728585 2018-08-07

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Children's Oncology Group

Phase 2 Withdrawn
Other

Neoplasms, Mucositis

NCT00626639 2017-06-21

A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

Swedish Orphan Biovitrum

Phase 1/2 Completed
5 enrolled 8 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡